90 related articles for article (PubMed ID: 10356365)
1. The SH3 and BH domains of the p85alpha adapter subunit play a critical role in regulating class Ia phosphoinositide 3-kinase function.
Beeton CA; Das P; Waterfield MD; Shepherd PR
Mol Cell Biol Res Commun; 1999 May; 1(2):153-7. PubMed ID: 10356365
[TBL] [Abstract][Full Text] [Related]
2. SH3 domain of the phosphatidylinositol 3-kinase regulatory subunit is responsible for the formation of a sequestration complex with insulin receptor substrate-1.
Ikegami Y; Inukai K; Awata T; Asano T; Katayama S
Biochem Biophys Res Commun; 2008 Jan; 365(3):433-8. PubMed ID: 17991427
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
Ren SY; Xue F; Feng J; Skorski T
Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
[TBL] [Abstract][Full Text] [Related]
4. Multiple domains of Ruk/CIN85/SETA/CD2BP3 are involved in interaction with p85alpha regulatory subunit of PI 3-kinase.
Borthwick EB; Korobko IV; Luke C; Drel VR; Fedyshyn YY; Ninkina N; Drobot LB; Buchman VL
J Mol Biol; 2004 Oct; 343(4):1135-46. PubMed ID: 15476827
[TBL] [Abstract][Full Text] [Related]
5. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit.
Ueki K; Algenstaedt P; Mauvais-Jarvis F; Kahn CR
Mol Cell Biol; 2000 Nov; 20(21):8035-46. PubMed ID: 11027274
[TBL] [Abstract][Full Text] [Related]
6. Cloning, expression, purification, and characterization of the human Class Ia phosphoinositide 3-kinase isoforms.
Meier TI; Cook JA; Thomas JE; Radding JA; Horn C; Lingaraj T; Smith MC
Protein Expr Purif; 2004 Jun; 35(2):218-24. PubMed ID: 15135396
[TBL] [Abstract][Full Text] [Related]
7. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes.
Kristensen SM; Siegal G; Sankar A; Driscoll PC
J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283
[TBL] [Abstract][Full Text] [Related]
8. Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice.
Aoki K; Matsui J; Kubota N; Nakajima H; Iwamoto K; Takamoto I; Tsuji Y; Ohno A; Mori S; Tokuyama K; Murakami K; Asano T; Aizawa S; Tobe K; Kadowaki T; Terauchi Y
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E842-53. PubMed ID: 19176357
[TBL] [Abstract][Full Text] [Related]
9. The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations.
Huang CH; Mandelker D; Schmidt-Kittler O; Samuels Y; Velculescu VE; Kinzler KW; Vogelstein B; Gabelli SB; Amzel LM
Science; 2007 Dec; 318(5857):1744-8. PubMed ID: 18079394
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance.
del Rincon JP; Iida K; Gaylinn BD; McCurdy CE; Leitner JW; Barbour LA; Kopchick JJ; Friedman JE; Draznin B; Thorner MO
Diabetes; 2007 Jun; 56(6):1638-46. PubMed ID: 17363744
[TBL] [Abstract][Full Text] [Related]
11. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain.
Hofmann BT; Jücker M
Cell Signal; 2012 Oct; 24(10):1950-4. PubMed ID: 22735814
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.
Beeton CA; Chance EM; Foukas LC; Shepherd PR
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
[TBL] [Abstract][Full Text] [Related]
14. Direct metabolic regulation of beta-catenin activity by the p85alpha regulatory subunit of phosphoinositide 3-OH kinase.
Espada J; Peinado H; Esteller M; Cano A
Exp Cell Res; 2005 May; 305(2):409-17. PubMed ID: 15817165
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
[TBL] [Abstract][Full Text] [Related]
16. Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases.
Hon WC; Berndt A; Williams RL
Oncogene; 2012 Aug; 31(32):3655-66. PubMed ID: 22120714
[TBL] [Abstract][Full Text] [Related]
17. p85alpha gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-Kinase), p50alpha, p55alpha, and p85alpha, with different PI 3-kinase activity elevating responses to insulin.
Inukai K; Funaki M; Ogihara T; Katagiri H; Kanda A; Anai M; Fukushima Y; Hosaka T; Suzuki M; Shin BC; Takata K; Yazaki Y; Kikuchi M; Oka Y; Asano T
J Biol Chem; 1997 Mar; 272(12):7873-82. PubMed ID: 9065454
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human skeletal muscle.
Shepherd PR; Navé BT; Rincon J; Nolte LA; Bevan AP; Siddle K; Zierath JR; Wallberg-Henriksson H
J Biol Chem; 1997 Jul; 272(30):19000-7. PubMed ID: 9228082
[TBL] [Abstract][Full Text] [Related]
19. Structural and biochemical evaluation of the interaction of the phosphatidylinositol 3-kinase p85alpha Src homology 2 domains with phosphoinositides and inositol polyphosphates.
Surdo PL; Bottomley MJ; Arcaro A; Siegal G; Panayotou G; Sankar A; Gaffney PR; Riley AM; Potter BV; Waterfield MD; Driscoll PC
J Biol Chem; 1999 May; 274(22):15678-85. PubMed ID: 10336465
[TBL] [Abstract][Full Text] [Related]
20. Expression and purification of PI3 kinase alpha and development of an ATP depletion and an alphascreen PI3 kinase activity assay.
Boldyreff B; Rasmussen TL; Jensen HH; Cloutier A; Beaudet L; Roby P; Issinger OG
J Biomol Screen; 2008 Dec; 13(10):1035-40. PubMed ID: 19036708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
